Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation

BackgroundFrailty predicts poorer outcomes and decreased anticoagulation use in patients with nonvalvular atrial fibrillation. We sought to assess the effectiveness and safety of apixaban, dabigatran and rivaroxaban versus warfarin in frail nonvalvular atrial fibrillation patients. Methods and Resul...

Full description

Bibliographic Details
Main Authors: Brandon K. Martinez, Nitesh A. Sood, Thomas J. Bunz, Craig I. Coleman
Format: Article
Language:English
Published: Wiley 2018-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulants
atrial fibrillation
direct‐acting oral anticoagulants
frailty
warfarin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.008643

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.008643

Similar Items